Search results for "hypomania"

showing 6 items of 6 documents

The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions

2017

Cardio-vascular diseases (CVDs) and CVD-related disorders (including cerebrovascular diseases; CBVDs) are a major public health concern as they represent the leading cause of mortality and morbidity in developed countries. Patients with CVDs and CBVDs co-morbid with mood disorders, especially bipolar disorder (BD) and major depressive disorder (MDD), suffer reduced quality-of-life and significant disability adjusted for years of life and mortality. The relationship between CVDs/CBVDs and mood disorders is likely to be bidirectional. Evidence for shared genetic risk of pathways involved in stress reaction, serotonin or dopamine signalling, circadian rhythms, and energy balance was reported i…

cognitionmedicine.medical_specialtyPsychological interventionphysical activity03 medical and health sciences0302 clinical medicineNeurobiologycardiovascular diseasemental disordersmedicineHumansBipolar disorderPsychiatrybipolar disorderpsychopharmacologyexerciseMood DisordersDepression; bipolar disorder; cardiovascular disease; cognition; comorbidity; exercise; physical activity; psychopharmacology; quality-of-life; strokeDepressionmedicine.diseaseComorbiditystroke030227 psychiatryCerebrovascular DisordersPsychiatry and Mental healthcomorbidityMoodHypomaniaMood disordersquality-of-lifeMajor depressive disordermedicine.symptomPsychologybipolar disorder; cardiovascular disease; cognition; comorbidity; Depression; exercise; physical activity; psychopharmacology; quality-of-life; strokeMania030217 neurology & neurosurgeryClinical psychology
researchProduct

Neurocognitive impairment and psychosocial functioning in bipolar II disorder

2011

Sole B, Bonnin CM, Torrent C, Balanza-Martinez V, Tabares-Seisdedos R, Popovic D, Martinez-Aran A, Vieta E. Neurocognitive impairment and psychosocial functioning in bipolar II disorder. Objective:  There is a growing body of evidence on neurocognitive impairment in euthymic bipolar patients, but this issue has been studied mostly in bipolar I disorder, data on bipolar II (BD-II) are scant and discrepant. The two aims of this study were to ascertain whether strictly defined euthymic BD-II patients would present neurocognitive disturbances and to evaluate their impact on functional outcome. Method:  Forty-three BD-II patients and 42 demographically and educationally matched healthy subjects …

medicine.medical_specialtyBipolar I disorderTrail Making TestHamilton Rating Scale for DepressionVerbal learningmedicine.diseaseYoung Mania Rating ScalePsychiatry and Mental healthBipolar II disorderHypomaniamedicinemedicine.symptomPsychologyPsychiatryNeurocognitiveActa Psychiatrica Scandinavica
researchProduct

Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: A review

2012

Compare reported rates of mood-shifts from major depression to mania/hypomania/mixed-states during antidepressant (AD)-treatment and rates of diagnostic change from major depressive disorder (MDD) to bipolar disorder (BPD).Searching computerized literature databases, followed by summary analyses.In 51 reports of patients diagnosed with MDD and treated with an AD, the overall risk of mood-switching was 8.18% (7837/95,786) within 2.39 ± 2.99 years of treatment, or 3.42 (95% CI: 3.34-3.50) %/year. Risk was 2.6 (CI: 2.5-2.8) times greater with/without AD-treatment by meta-analysis of 10 controlled trials. Risk increased with time up to 24 months of treatment, with no secular change (1968-2012).…

Depressive Disorder Majormedicine.medical_specialtyPediatricsBipolar Disordermedicine.diseaseRisk Assessmentbehavioral disciplines and activitiesAntidepressive AgentsPsychiatry and Mental healthClinical PsychologyTreatment OutcomeMoodHypomaniamental disordersmedicineHumansAntidepressantMajor depressive disorderBipolar disordermedicine.symptomPsychiatryPsychologyManiaDepression (differential diagnoses)Randomized Controlled Trials as TopicJournal of Affective Disorders
researchProduct

Stability in MMPI among adoptees with high and low genetic risk for schizophrenia and with low Communication Deviance of their adoptive parents.

2013

Abstract Stability has been considered an important aspect of vulnerability to schizophrenia. The temporal stability of the scales in the Minnesota Multiphasic Personality Inventory (MMPI) was examined, using adoptees from the Finnish Adoptive Family Study of Schizophrenia. Adoptees who were high-risk (HR) offspring of biological mothers having a schizophrenia spectrum disorder ( n =28) and low-risk (LR) controls ( n =46) were evaluated using 15 MMPI scales at the initial assessment (HR, mean age 24 years; LR, mean age 23 years) and at the follow-up assessment after a mean interval of 11 years. Stability of the MMPI scales was also assessed in the groups of adoptees, assigned according to t…

AdultMaleParentsParanoid schizophreniaAdolescentHostilityAdoption studyEnvironmentDevelopmental psychologyYoung AdultCommunication devianceMinnesota Multiphasic Personality InventoryMMPIPsychoticismmental disordersAdoptionmedicineHumansta515Biological PsychiatryFinlandAnalysis of VarianceCommunicationmedicine.diseasePsychiatry and Mental healthHypomaniaSchizophreniaSchizophreniaFemaleSchizophrenic Psychologymedicine.symptomPsychologyPersonalityPsychiatry research
researchProduct

Loss Aversion and Risk Aversion in Non-Clinical Negative Symptoms and Hypomania

2020

In the field of behavioral decision-making, “loss aversion” is a behavioral phenomenon in which individuals show a higher sensitivity to potential losses than to gains. Conversely, “risk averse” individuals have an enhanced sensitivity/aversion to options with uncertain consequences. Here we examine whether hypomania or negative symptoms predict the degree of these choice biases. We chose to study these two symptom dimensions because they present a common theme across many syndromes with compromised decision-making. In our exploratory study, we employed a non-clinical sample to dissociate the hypomanic from negative symptom dimension regarding choice behavior. We randomly selected a sample …

lcsh:RC435-571610 Medicine & healthLoss-aversionAffect (psychology)loss-aversion170 Ethics2738 Psychiatry and Mental Health03 medical and health sciencesddc:616.890302 clinical medicineLoss aversionlcsh:PsychiatrymedicineEnhanced sensitivity10237 Institute of Biomedical EngineeringRisk-aversionrisk-aversionnegative symptomsPsychiatryNegative symptomStudent populationRisk aversiondecision-makingBrief Research ReportHypomania030227 psychiatryPsychiatry and Mental healthHypomaniaNon clinical10054 Clinic for Psychiatry Psychotherapy and Psychosomaticsloss-aversion; risk-aversion; decision-making; negative symptoms; hypomaniahypomaniaNegative symptomsmedicine.symptomPsychology030217 neurology & neurosurgeryClinical psychologyDecision-makingFrontiers in Psychiatry
researchProduct

The Psychopathy Checklist and non-violent offender groups

1992

Cleckley’s concept of psychopathy includes characteristics such as superficial charm, unreliability, and affective poverty. In this study, the Psychopathy Checklist (PCL) and personality questionnaires (MMPI, CPI, EPQ, and SSS) were used to assess 92 non-violent male offenders. The variable-based approach was applied in order to study the structure of the PCL and the relationships between the PCL, the PCL factors and the personality questionnaire scores. The results indicated that the personality scale scores failed to correlate positively with the PCL score, with the exception of the MMPI hypomania score. Two PCL factors emerged: factor 1 related to the core personality characteristics of …

medicine.medical_specialtymedia_common.quotation_subjectPsychopathyPoison controlPathology and Forensic MedicineMinnesota Multiphasic Personality InventorymedicinePersonality0501 psychology and cognitive sciencesPsychiatry0505 lawmedia_commonPsychopathy ChecklistDark triad05 social sciencesSuperficial charmGeneral Medicinemedicine.diseasePsychiatry and Mental healthHypomania050501 criminologyPsychology (miscellaneous)medicine.symptomPsychology050104 developmental & child psychologyClinical psychologyCriminal Behaviour and Mental Health
researchProduct